MIRA PHARMACEUTICALS, INC. (MIRA) - Dilution Analysis

10-Q filing | 41.9M shares outstanding

8-K filing: MIRA Pharmaceuticals, Inc. sold 1,751,000 shares of its common stock at an average price of $2.19 per share in block sales to multiple institutional investors through its at-the-market equity offering, resulting in gross proceeds of approximately $3,835,485. ($3.84M proceeds)

10-Q filing | 19.1M shares outstanding

8-K filing: MIRA Pharmaceuticals, Inc. sold 1,550,741 shares of its common stock at an average price of $1.2981 per share in block sales to an institutional investor, through its at-the-market equity offering facility, resulting in gross proceeds of approximately $2.0 million. ($2.0M proceeds)

10-Q filing | 16.6M shares outstanding

10-K filing | 15.4M shares outstanding

10-Q filing | 15.1M shares outstanding

10-Q filing | 14.8M shares outstanding

S-3 filing: Mira Pharmaceuticals Inc. may offer and sell, from time to time, in one or more offerings, any combination of common stock and/or preferred stock with an aggregate initial offering price not to exceed $100,000,000.

10-Q filing | 14.8M shares outstanding

10-K filing | 14.8M shares outstanding

S-1 filing: This S-1 filing is for the resale of up to 1,700,000 shares of common stock by selling stockholders.

8-K filing: MIRA Pharmaceuticals, Inc. entered into an exclusive license agreement with MIRALOGX, LLC for a drug product, issued a Common Stock Purchase Warrant to MIRALOGX to purchase up to 700,000 shares at $2.00 per share, and entered into a Loan Agreement with MIRALOGX allowing the Company to borrow up to $3.0 million.

10-Q filing | 13.6M shares outstanding

10-Q filing | 13.3M shares outstanding

8-K filing: MIRA Pharmaceuticals, Inc. completed a public offering of 1,275,000 shares of common stock at $7.00 per share, resulting in gross proceeds of approximately $8,925,000, and issued 35,715 shares of common stock to MZHCI, LLC for services related to the offering. ($8.93M proceeds)

S-1/A filing: This is an initial public offering of 1,275,000 shares of common stock at $7.00 per share.

S-1/A filing: The company undertook a private placement from November 2021 to December 2022, issuing 1,539,200 shares of common stock at $5.00 per share for an aggregate purchase price of approximately $7.7 million to 90 investors.

S-1/A filing: Initial public offering of 1,200,000 shares of common stock at an assumed initial public offering price of $7.00 per share.

S-1/A filing: This is an S-1/A filing for the initial public offering of 1,000,000 shares of common stock, with an estimated price range of $6.00 to $8.00 per share. The underwriters also have an option to purchase an additional 150,000 shares.

S-1 filing: Initial public offering of common stock with underwriters having an option to purchase additional shares.